Abstract:Fibronectin (FN) is a ubiquitous extracellular matrix glycoprotein essential for the development of various tissues. Mutations in FN cause a unique form of spondylometaphyseal dysplasia, emphasizing its importance in cartilage and bone development. However, the relevance and functional role of FN during skeletal development has remained elusive. To address these aspects, we have generated conditional knockout mouse models targeting the cellular FN isoform in cartilage (cFNKO), the plasma FN isoform in hepatocytes (pFNKO), and both isoforms together in a double knockout (FNdKO). We used these mice to determine the relevance of the two principal FN isoforms in skeletal development from P1 to the adult stage at two months. We identified a distinct topological FN deposition pattern in the mouse limb during different gestational and postnatal skeletal development phases, with prominent levels at the resting and hypertrophic chondrocyte zones and in the trabecular bone. Cartilage-specific cFN emerged as the predominant isoform in the growth plate, whereas circulating pFN remained excluded from the growth plate and confined to the primary and secondary ossification centers. Deleting either isoform independently (cFNKO or pFNKO) yielded only relatively subtle changes in the analyzed skeletal parameters. However, the double knockout of cFN in the growth plate and pFN in the circulation of the FNdKO mice significantly reduced postnatal body weight, body length, and bone length. Micro-CT analysis of the adult bone microarchitecture in FNdKO mice exposed substantial reductions in trabecular bone parameters and bone mineral density. The mice also showed elevated bone marrow adiposity. Analysis of chondrogenesis in FNdKO mice demonstrated changes in the resting, proliferating and hypertrophic growth plate zones, consistent alterations in chondrogenic markers such as collagen type II and X, decreased apoptosis of hypertrophic chondrocytes, and downregulation of bone formation markers. Transforming growth factor-β1 and downstream phospho-AKT levels were significantly lower in the FNdKO than in the control mice, revealing a crucial FN-mediated regulatory pathway in chondrogenesis and bone formation. In conclusion, the data demonstrate that FN is essential for chondrogenesis and bone development. Even though cFN and pFN act in different regions of the bone, both FN isoforms are required for the regulation of chondrogenesis, cartilage maturation, trabecular bone formation, and overall skeletal growth.

Fibroblast growth factors in skeletal development

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Roles of FGF signaling in skeletal development and human genetic diseases.

Functional Diversity of Fibroblast Growth Factors in Bone Formation

Roles of FGF receptors in mammalian development and congenital diseases.

The Integral Role of Fibronectin in Skeletal Morphogenesis and Pathogenesis

Role of Fibronectin in Postnatal Skeletal Development

Fibroblast growth factors, old kids on the new block

Fibronectin Isoforms Promote Postnatal Skeletal Development

Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family

Fibroblast Growth Factor Receptor 2 (Fgfr2)-Mediated Reciprocal Regulation Loop Between FGF8 and FGF10 is Essential for Limb Induction

The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration

A combined series of Fgf9 and Fgf18 mutant alleles identifies unique and redundant roles in skeletal development

Role of the fibroblast growth factor 19 in the skeletal system

Fibroblast Growth-Factor Receptor-3 Is A Negative Regulator Of Bone-Growth And Development

FGF/FGFR signaling in health and disease

Deregulated Bone Morphogenetic Protein Receptor Signaling Underlies Fibrodysplasia Ossificans Progressiva.

Functions of exogenous FGF signals in regulation of fibroblast to myofibroblast differentiation and extracellular matrix protein expression

FGF signaling patterns cell fate at the interface between tendon and bone

Therapeutic uses of FGFs

The role of fibroblast growth factor 7 in cartilage development and diseases